Kent's SnapshotNIR is the latest advancement in tissue oxygenation imaging. The cost effective and easy to use imaging device is completely non-invasive, eliminating the need for patient contact or the injected dyes required by other technologies. Instantly capture diagnostic insight into the availability of oxygenated blood in tissue. Providing improved decision making throughout the dynamic treatment pathway – before, during and after wound or surgical care.
Location: Canada, Alberta, Calgary
Employees: 11-50
Phone: +1 833-733-5368
Total raised: $15M
Founded date: 2006
Investors 1
Date | Name | Website |
14.01.2021 | TVM Capita... | tvm-lifesc... |
Funding Rounds 1
Date | Series | Amount | Investors |
14.01.2021 | - | $15M | TVM Capita... |
Mentions in press and media 16
Date | Title | Description |
10.09.2024 | Pierre Lemire, CEO of Kent Imaging, to Present at LSI Europe in Portugal this September | Kent Imaging Pierre Lemire to present at LSI Europe 2024 Canadian MedTech innovator, Pierre Lemire, will be at LSI Europe 2024 to present the Snapshot Platform of light-based imaging technology. When we compare against the standard of care,... |
11.06.2024 | SnapshotNIR Used to Predict Skin Flap Necrosis Intra-Operatively in Oncologic Resection Reconstruction | SnapshotNIR color image and tissue oxygen saturation image. Tissue oxygen saturation measurement accurately predicted skin flap necrosis in oncologic breast reconstruction surgeries. CALGARY, ALBERTA, CANADA, June 11, 2024 /EINPresswire.com... |
13.05.2024 | SAWC Spring will be in Full Bloom with Evidence for Near-Infrared Spectroscopy | Kent Imaging will be exhibiting at SAWC Spring demonstrating the new proprietary algorithm of the SnapshotNIR (KD205) device. This year is especially exciting as we are showcasing Snapshot KD205 keeping Kent at the forefront with an imaging... |
30.04.2024 | Kent Imaging Announces FDA Clearance of SnapshotNIR KD205 | SnapshotNIR KD205 Kent Imaging announces the latest model of SnapshotNIR that expands the use of the technology to include more skin tones, advancing tissue assessment. It’s progress like this that can move the needle forward for immediate,... |
08.04.2024 | Kent Imaging is excited to announce Daryl Reed as the Vice President of Global Sales | Kent Imaging Daryl Reed brings considerable expertise in medical devices and wound care to the Kent Imaging sales team as the newly appointed Vice President of Global Sales. The timing is optimal as Kent is experiencing explosive growth, an... |
16.01.2024 | Important CPT® Code Updates for Kent Imaging’s SnapshotNIR and New Code for PAD Screening | CMS Updates APC Reimbursement Codes - Another positive step in helping to improve patient outcomes with near-infrared spectroscopy technology. This is another positive step in our efforts to help improve patient outcomes with SnapshotNIR. ”... |
21.06.2023 | Executive Global Magazine Features Canadian MedTech Pioneer, Pierre Lemire, on Cover with an Exclusive Interview | Kent Imaging CEO, Pierre Lemire, speaks about entrepreneurship and how imaging technology and the rise of AI are changing the healthcare industry. The technology we are developing is changing how clinicians treat acute and chronic wounds wi... |
28.02.2023 | Kent Imaging Receives MedTech Innovation Award | Corporate America, 2023 The company has been selected as Most Innovative Medical Imaging Technology Developer in Canada, from Corporate America. CALGARY, AB, CANADA, February 28, 2023 /EINPresswire.com/ -- Kent Imaging is pleased to announc... |
25.10.2022 | Kent Imaging Appoints Glyn Jones, MD as Chief Medical Officer of Reconstructive Surgery | Glyn Jones, MD, FACS Experienced health executive and renowned reconstructive surgeon brings proven expertise and guidance on the use of near-infrared imaging technology. CALGARY, AB, CANADA, October 25, 2022 /EINPresswire.com/ -- Kent Imag... |
07.07.2022 | Kent Imaging is Providing Actionable Data to Assist with Wound Healing and Support Positive Patient Outcomes | Kent's CEO, Pierre Lemire, with SnapshotNIR Kent Imaging's CEO, Pierre Lemire, interviewed for CEOCFO Magazine Diagnostic-driven tools like SnapshotNIR are extremely valuable in really understanding what is happening below the surface in th... |
Show more